OOIR: Observatory of International Research

Papers

(The H4-Index of Eye is 35. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-04-01 to 2024-04-01.)

Article	Citations
Infectious keratitis: an update on epidemiology, causative microorganisms, risk factors, and antimicrobial resistance	180
Expression of SARS-CoV-2 receptor ACE2 and TMPRSS2 in human primary conjunctival and pterygium cell lines and in mouse cornea	174
Paracentral acute middle maculopathy and acute macular neuroretinopathy following SARS-CoV-2 infection	125
Reshaping ophthalmology training after COVID-19 pandemic	98
Optical coherence tomography angiography in diabetic retinopathy: an updated review	92
Detection of severe acute respiratory syndrome Coronavirus-2 in the tears of patients with Coronavirus disease 2019	89
Diabetic retinopathy and diabetic macular oedema pathways and management: UK Consensus Working Group	83
The impact of COVID policies on acute ophthalmology services—experiences from Moorfields Eye Hospital NHS Foundation Trust	77
Angiopoietin/Tie2 signalling and its role in retinal and choroidal vascular diseases: a review of preclinical data	75
Ocular benzalkonium chloride exposure: problems and solutions	73
Coronavirus disease 2019 (SARS-CoV-2) and colonization of ocular tissues and secretions: a systematic review	70
Refractive surgery beyond 2020	62
Oculoplastic video-based telemedicine consultations: Covid-19 and beyond	61
Impact of macular fluid volume fluctuations on visual acuity during anti-VEGF therapy in eyes with nAMD	56
Deep learning in glaucoma with optical coherence tomography: a review	54
Review of retinal cameras for global coverage of diabetic retinopathy screening	53
Deep learning-based automated detection for diabetic retinopathy and diabetic macular oedema in retinal fundus photographs	53
Concerns about the interpretation of OCT and fundus findings in COVID-19 patients in recent Lancet publication	53
Transforming ophthalmic education into virtual learning during COVID-19 pandemic: a global perspective	52
Brolucizumab—early real-world experience: BREW study	51
Conventional glaucoma implants and the new MIGS devices: a comprehensive review of current options and future directions	50
Ophthalmic manifestations of monkeypox virus	48
Changing trends of ocular trauma in the time of COVID-19 pandemic	48
Acute macular neuroretinopathy following COVID-19 vaccination	47
Recent trends in vision impairment certifications in England and Wales	47

Taking the right measures to control COVID-19 in ophthalmology: the experience of a tertiary eye care referral center in Italy	45
Ocular coloboma—a comprehensive review for the clinician	44
Chemical eye injury: pathophysiology, assessment and management	41
Optical coherence tomography in the 2020s—outside the eye clinic	40
Dupilumab-associated ocular surface disease: presentation, management and long-term sequelae	40
Drusen and pachydrusen: the definition, pathogenesis, and clinical significance	39
Review of gene therapies for age-related macular degeneration	38
Psychosocial impact of COVID-19 pandemic lockdown on people living with eye diseases in the UK	37
Teprotumumab for the treatment of chronic thyroid eye disease	36
Optical coherence tomography (OCT) in neuro-ophthalmology	36
The COVID-19 pandemic will redefine the future delivery of glaucoma care	35
Natural history of patients with Leber hereditary optic neuropathy—results from the REALITY study	35
The effect of home education on myopia progression in children during the COVID-19 pandemic	35
Accuracy of a new intraocular lens power calculation method based on artificial intelligence	35